Skip to main content

What the FDA labels say about taking them together

Lidocaine/tetracaine and mexiletine

Lidocaine/tetracaine's FDA label of March 9, 2026 names mexiletine in its drug interactions section; the mexiletine label PlainMeds reads does not name lidocaine/tetracaine.

Check it at the source: the lidocaine/tetracaine FDA label on DailyMed (effective March 9, 2026, IPG PHARMACEUTICALS, INC.); the mexiletine FDA label on DailyMed (effective May 14, 2026, Macleods Pharmaceuticals Limited).

What does the lidocaine/tetracaine label say about mexiletine?

Lidocaine/tetracaine label, drug interactions

Antiarrhythmic Drugs PLIAGLIS should be used with caution in patients receiving Class I antiarrhythmic drugs (such as tocainide and mexiletine) since the systemic toxic effects are thought to be additive and potentially synergistic with lidocaine and tetracaine.

Source: FDA drug label (PLIAGLIS), NDA021717 (Crescita Therap), as published by IPG PHARMACEUTICALS, INC., effective March 9, 2026 (SPL set d854faa5-0af8-4684-b5cd-a0b8a91fb7cd), via openFDA; the full label on DailyMed

What does the mexiletine label say about lidocaine/tetracaine?

Mexiletine's label (effective May 14, 2026) does not name lidocaine/tetracaine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Mexiletine Hydrochloride), Macleods Pharmaceuticals Limited, effective May 14, 2026 (SPL set a61a07f6-0b48-4dcd-ad42-5d90f6e69ab1), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Lidocaine/tetracaine generic labelers
14Mexiletine generic labelers
Lidocaine/tetracaineMexiletine
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)n/a$0.222 per capsule 150 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?